Combined evaluation of plasma B-type natriuretic peptide and urinary liver-type fatty acid-binding protein/creatinine ratio is related to worsening renal function in patients undergoing elective percutaneous coronary intervention.
Fumiki YoshiharaHiroshi HosodaTakahito DoiMorikatsu YoshidaKazuo KitamuraHaruko YamamotoYasuhide AsaumiHatsue Ishibashi-UedaMasatsugu KishidaTetsuya ArisatoMiki MatsuoMikiya MiyazatoSatoshi YasudaPublished in: Clinical and experimental nephrology (2021)
Our results suggest that combined evaluation of plasma BNP and urinary L-FABP/Cr is useful as a predictor of renal dysfunction in CAG/PCI patients.
Keyphrases
- percutaneous coronary intervention
- patients undergoing
- binding protein
- end stage renal disease
- fatty acid
- acute coronary syndrome
- acute myocardial infarction
- coronary artery disease
- st segment elevation myocardial infarction
- ejection fraction
- st elevation myocardial infarction
- chronic kidney disease
- antiplatelet therapy
- newly diagnosed
- oxidative stress
- atrial fibrillation
- prognostic factors
- heart failure
- peritoneal dialysis